Interaction between the bone morphogenetic proteins and Ras/MAP-kinase signalling pathways in lung cancer
- PMID: 16175182
- PMCID: PMC2361658
- DOI: 10.1038/sj.bjc.6602790
Interaction between the bone morphogenetic proteins and Ras/MAP-kinase signalling pathways in lung cancer
Abstract
Bone morphogenetic proteins (BMPs) are an integral component of the TGFbeta superfamily, responsible for regulation of cell proliferation, differentiation, migration and programmed cell death in a variety of cell types. The BMPs transduce their signals directly through the SMAD family of proteins but they also have been reported to interact with the MAPK and Erk pathways. Inactivation of the BMP pathway genes has been implicated as important in several cancers. Recent work has shown that BMP3b is epigenetically inactivated in cancer and suggests that BMP6 can be epigenetically inactivated. We investigated whether BMP6 is epigenetically inactivated in cell lines and whether BMP3b and BMP6 are epigenetically inactivated in non-small-cell lung cancer (NSCLC). We also studied the relationship between BMP methylation and k-ras mutation. Here, we demonstrate that the BMP3b and BMP6 genes are common targets of epigenetic inactivation in NSCLC, and that they are significantly more likely to be concurrently inactivated (P=0.009). Furthermore, this coinactivation of BMP3b and BMP6 is significantly associated with mutation of k-ras codon 12 in lung cancer (P=0.003); those with a k-ras mutation were six times more likely to have concurrent methylation of these BMP loci. Hence, these data suggest that concurrent inactivation of the BMP and activation of the Ras signalling pathways are important in lung carcinogenesis.
Figures

Similar articles
-
Bone morphogenetic protein 3B silencing in non-small-cell lung cancer.Oncogene. 2004 Apr 29;23(20):3521-9. doi: 10.1038/sj.onc.1207441. Oncogene. 2004. PMID: 15116090
-
The aberrant promoter methylation of BMP3b and BMP6 in malignant pleural mesotheliomas.Oncol Rep. 2008 Nov;20(5):1265-8. Oncol Rep. 2008. PMID: 18949431
-
The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells.Carcinogenesis. 2003 Sep;24(9):1445-54. doi: 10.1093/carcin/bgg100. Epub 2003 Jun 19. Carcinogenesis. 2003. PMID: 12819188
-
K-ras mutations in non-small-cell lung carcinoma: a review.Clin Lung Cancer. 2006 Jul;8(1):30-8. doi: 10.3816/CLC.2006.n.030. Clin Lung Cancer. 2006. PMID: 16870043 Review.
-
Gene methylation in gastric cancer.Clin Chim Acta. 2013 Sep 23;424:53-65. doi: 10.1016/j.cca.2013.05.002. Epub 2013 May 10. Clin Chim Acta. 2013. PMID: 23669186 Review.
Cited by
-
Analysis of the bone morphogenetic protein 6 gene promoter region in young beef cattle affected by enzootic bovine leukosis.J Vet Med Sci. 2021 Jun 9;83(6):898-904. doi: 10.1292/jvms.20-0663. Epub 2021 Apr 9. J Vet Med Sci. 2021. PMID: 33840719 Free PMC article.
-
The Dual Role of Bone Morphogenetic Proteins in Cancer.Mol Ther Oncolytics. 2017 Oct 24;8:1-13. doi: 10.1016/j.omto.2017.10.002. eCollection 2018 Mar 30. Mol Ther Oncolytics. 2017. PMID: 29234727 Free PMC article. Review.
-
CBX6 overexpression contributes to tumor progression and is predictive of a poor prognosis in hepatocellular carcinoma.Oncotarget. 2017 Mar 21;8(12):18872-18884. doi: 10.18632/oncotarget.14770. Oncotarget. 2017. PMID: 28122351 Free PMC article.
-
Down-regulation of S100A9 inhibits osteosarcoma cell growth through inactivating MAPK and NF-κB signaling pathways.BMC Cancer. 2016 Mar 28;16:253. doi: 10.1186/s12885-016-2294-1. BMC Cancer. 2016. PMID: 27020242 Free PMC article.
-
Polymorphisms in bone morphogenetic protein 3 and the risk of papillary thyroid cancer.Oncol Lett. 2013 Jan;5(1):336-340. doi: 10.3892/ol.2012.962. Epub 2012 Oct 10. Oncol Lett. 2013. PMID: 23255945 Free PMC article.
References
-
- An Q, Liu Y, Gao Y, Huang J, Fong X, Liu L, Zhang D, Zhang J, Cheng S (2002) Deletion of tumor suppressor genes in Chinese non-small cell lung cancer. Cancer Lett 184: 189–195 - PubMed
-
- Baldus SE, Schwarz E, Lohrey C, Zapatka M, Landsberg S, Hahn SA, Schmidt D, Dienes HP, Schmiegel WH, Schwarte-Waldhoff I (2004) Smad4 deficiency in cervical carcinoma cells. Oncogene 24: 810–819 - PubMed
-
- Brubaker KD, Corey E, Brown LG, Vessella RL (2004) Bone morphogenetic protein signaling in prostate cancer cell lines. J Cell Biochem 91: 151–160 - PubMed
-
- Cunningham JM, Weinberg RA (1985) Ras oncogenes in human tumours: identification, mechanism of activation and cooperative role in transformation. IARC Sci Publ 60: 359–364 - PubMed
-
- Dai Z, Popkie AP, Zhu WG, Timmers CD, Raval A, Tannehill-Gregg S, Morrison CD, Auer H, Kratzke RA, Niehans G, Amatschek S, Sommergruber W, Leone GW, Rosol T, Otterson GA, Plass C (2004) Bone morphogenetic protein 3B silencing in non-small-cell lung cancer. Oncogene 23: 3521–3529 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous